NO961746L - Fenylindolforbindelser - Google Patents

Fenylindolforbindelser

Info

Publication number
NO961746L
NO961746L NO961746A NO961746A NO961746L NO 961746 L NO961746 L NO 961746L NO 961746 A NO961746 A NO 961746A NO 961746 A NO961746 A NO 961746A NO 961746 L NO961746 L NO 961746L
Authority
NO
Norway
Prior art keywords
pct
date
sec
fenylindolforbindelser
pub
Prior art date
Application number
NO961746A
Other languages
English (en)
Other versions
NO309038B1 (no
NO961746D0 (no
Inventor
Jens Kristian Perregaard
Ejner Knud Moltzen
Kim Andersen
Henrik Pedersen
Klaus Peter Boegesoe
Andre Pernet
Barbara Bopp
Darcy Mulford
Kiyoshi Sakamoto
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO961746D0 publication Critical patent/NO961746D0/no
Publication of NO961746L publication Critical patent/NO961746L/no
Publication of NO309038B1 publication Critical patent/NO309038B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Sewing Machines And Sewing (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Polyurethanes Or Polyureas (AREA)
NO961746A 1993-11-01 1996-04-30 Fenylindolforbindelser NO309038B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK931234A DK123493D0 (da) 1993-11-01 1993-11-01 Compounds
PCT/DK1994/000407 WO1995012591A1 (en) 1993-11-01 1994-10-28 Phenylindole compounds

Publications (3)

Publication Number Publication Date
NO961746D0 NO961746D0 (no) 1996-04-30
NO961746L true NO961746L (no) 1996-06-28
NO309038B1 NO309038B1 (no) 2000-12-04

Family

ID=8102507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961746A NO309038B1 (no) 1993-11-01 1996-04-30 Fenylindolforbindelser

Country Status (26)

Country Link
US (1) US5703087A (no)
EP (1) EP0726898B1 (no)
JP (1) JP3898219B2 (no)
KR (1) KR100350550B1 (no)
CN (1) CN1134149A (no)
AT (1) ATE198199T1 (no)
AU (1) AU683700B2 (no)
CA (1) CA2175498C (no)
CZ (1) CZ291403B6 (no)
DE (1) DE69426462T2 (no)
DK (2) DK123493D0 (no)
ES (1) ES2154303T3 (no)
FI (1) FI116623B (no)
GR (1) GR3035462T3 (no)
HU (1) HUT76063A (no)
IL (2) IL111395A (no)
LV (1) LV12805B (no)
NO (1) NO309038B1 (no)
NZ (1) NZ275086A (no)
PL (1) PL176391B1 (no)
PT (1) PT726898E (no)
RU (1) RU2156249C2 (no)
SI (1) SI0726898T1 (no)
SK (1) SK281761B6 (no)
WO (1) WO1995012591A1 (no)
ZA (1) ZA948589B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489341B1 (en) * 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
EP1214312B1 (en) * 1999-09-09 2004-04-14 H. Lundbeck A/S 5-aminoalkyl and 5-aminocarbonyl substituted indoles
US20070212412A1 (en) * 2005-09-08 2007-09-13 H. Lundbeck A/S Stable solid formulation of sertindole
TW200821296A (en) * 2006-06-01 2008-05-16 Lundbeck & Co As H Use of sertindole for the preventive treatment of suicidal behaviour
PL2509961T3 (pl) * 2009-12-11 2016-09-30 Pochodne imidazolidynodionu
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
ES2560304T3 (es) 2010-12-06 2016-02-18 Autifony Therapeutics Limited Derivados de hidantoína útiles como inhibidores de Kv3
EP2718285B1 (en) * 2011-06-07 2016-03-16 Autifony Therapeutics Limited Hydantoin derivatives as kv3 inhibitors
CN103974944B (zh) * 2011-12-06 2016-11-02 奥蒂福尼疗法有限公司 用作kv3抑制剂的乙内酰脲衍生物
EP2852588B8 (en) 2012-05-22 2018-01-10 Autifony Therapeutics Limited Hydantoin derivatives as kv3 inhibitors
WO2013175215A1 (en) 2012-05-22 2013-11-28 Autifony Therapeutics Limited Triazoles as kv3 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DK152090D0 (da) * 1990-06-22 1990-06-22 Lundbaek A S H Piperidylsubstituerede indolderivater

Also Published As

Publication number Publication date
EP0726898B1 (en) 2000-12-20
KR960705814A (ko) 1996-11-08
PL314181A1 (en) 1996-08-19
CZ124896A3 (en) 1996-09-11
KR100350550B1 (ko) 2002-12-12
IL111394A0 (en) 1994-12-29
CA2175498A1 (en) 1995-05-11
SK53496A3 (en) 1996-11-06
FI116623B (fi) 2006-01-13
FI961844L (fi) 1996-04-30
NO309038B1 (no) 2000-12-04
RU2156249C2 (ru) 2000-09-20
ES2154303T3 (es) 2001-04-01
US5703087A (en) 1997-12-30
SI0726898T1 (en) 2001-04-30
PT726898E (pt) 2001-05-31
IL111395A (en) 1999-06-20
FI961844A0 (fi) 1996-04-30
PL176391B1 (pl) 1999-05-31
EP0726898A1 (en) 1996-08-21
ATE198199T1 (de) 2001-01-15
NO961746D0 (no) 1996-04-30
DE69426462D1 (de) 2001-01-25
CZ291403B6 (cs) 2003-03-12
CA2175498C (en) 2005-07-26
NZ275086A (en) 1997-10-24
WO1995012591A1 (en) 1995-05-11
IL111394A (en) 1998-08-16
LV12805B (lv) 2002-05-20
HU9601144D0 (en) 1996-07-29
JPH09506083A (ja) 1997-06-17
DE69426462T2 (de) 2001-04-26
DK0726898T3 (da) 2001-04-30
DK123493D0 (da) 1993-11-01
AU8057794A (en) 1995-05-23
HUT76063A (en) 1997-06-30
IL111395A0 (en) 1994-12-29
ZA948589B (en) 1995-06-26
GR3035462T3 (en) 2001-05-31
SK281761B6 (sk) 2001-07-10
AU683700B2 (en) 1997-11-20
LV12805A (en) 2002-03-20
CN1134149A (zh) 1996-10-23
HK1013817A1 (en) 1999-09-10
JP3898219B2 (ja) 2007-03-28

Similar Documents

Publication Publication Date Title
GR960100438A (el) Νεα παρασιτοκτονα.
ATE229524T1 (de) Distamycin a analoga als antitumor- oder antivirale wirkstoffe
ATE185797T1 (de) Stilben-derivate verwendbar als cyclooxygenase-2 hemmer
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
PT100606A (pt) Derivados fluoroalcoxibenzilamino de heterociclos contendo azoto
NO962286D0 (no) N-substituerte azabicykloalkanderivater som neuroleptika etc.
ES2194202T3 (es) Compuestos polimorfos.
DK0772604T3 (da) Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander
ES2162907T3 (es) 3-acilaminobenzacepinas.
ATE198199T1 (de) Phenylindolverbindungen
DK0833626T3 (da) Mono- og disulfosubstituerede anthraquioner og deres anvendelse til behandlingen af knoglematrixforstyrrelser
DK0775113T3 (da) N-substituerede azabicycloheptan-derivater som neuroleptika osv.
ATE209205T1 (de) Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
ATE177098T1 (de) Mercaptoacetylamid disulfidderivate als enkephalinase und ace inhibitoren

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees